1. Ye, Yangfan, Xu, Lei, Zhang, Liuchao, Tu, Yiming, Ji, Jing. 2024. Meningioma achieves malignancy and erastin-induced ferroptosis resistance through FOXM1-AURKA-NRF2 axis. In Redox biology, 72, 103137. doi:10.1016/j.redox.2024.103137. https://pubmed.ncbi.nlm.nih.gov/38642502/
2. Jia, Xiao, Tian, Jiao, Fu, Yueyue, Yang, Cheng, Liu, Yijin. 2024. Identification of AURKA as a Biomarker Associated with Cuproptosis and Ferroptosis in HNSCC. In International journal of molecular sciences, 25, . doi:10.3390/ijms25084372. https://pubmed.ncbi.nlm.nih.gov/38673957/
3. Chen, Menghua, Zhu, Huijun, Li, Jian, Liu, Wenqi, Wang, Jue. 2024. Research progress on the relationship between AURKA and tumorigenesis: the neglected nuclear function of AURKA. In Annals of medicine, 56, 2282184. doi:10.1080/07853890.2023.2282184. https://pubmed.ncbi.nlm.nih.gov/38738386/
4. Yan, Min, Wang, Chunli, He, Bin, Jin, Bilian, Liu, Quentin. 2016. Aurora-A Kinase: A Potent Oncogene and Target for Cancer Therapy. In Medicinal research reviews, 36, 1036-1079. doi:10.1002/med.21399. https://pubmed.ncbi.nlm.nih.gov/27406026/
5. Farid, Ann Abd-Almonem, Afify, Nermin Abd-Almaksoud, Alsharnoby, Aml Abd-Alhamid, Abdelsameea, Eman, Bedair, Hanan M. 2021. Predictive Role of AURKA rs 1047972 Gene Polymorphism and the Risk of Development of Hepatocellular Carcinoma. In Immunological investigations, 51, 1211-1221. doi:10.1080/08820139.2021.1920609. https://pubmed.ncbi.nlm.nih.gov/34018460/
6. Gritsina, Galina, Fong, Ka-Wing, Lu, Xiaodong, Hussain, Maha, Yu, Jindan. 2023. Chemokine receptor CXCR7 activates Aurora Kinase A and promotes neuroendocrine prostate cancer growth. In The Journal of clinical investigation, 133, . doi:10.1172/JCI166248. https://pubmed.ncbi.nlm.nih.gov/37347559/
7. Xie, Yangchun, Zhu, Shan, Zhong, Meizuo, Kang, Rui, Tang, Daolin. 2017. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma. In Gastroenterology, 153, 1429-1443.e5. doi:10.1053/j.gastro.2017.07.036. https://pubmed.ncbi.nlm.nih.gov/28764929/
8. Fuentes-Antrás, Jesús, Bedard, Philippe L, Cescon, David W. . Seize the engine: Emerging cell cycle targets in breast cancer. In Clinical and translational medicine, 14, e1544. doi:10.1002/ctm2.1544. https://pubmed.ncbi.nlm.nih.gov/38264947/
9. Wang, Xiaobo, Huang, Jing, Liu, Fenglin, Zhang, Yuanyuan, Dang, Yongjun. 2023. Aurora A kinase inhibition compromises its antitumor efficacy by elevating PD-L1 expression. In The Journal of clinical investigation, 133, . doi:10.1172/JCI161929. https://pubmed.ncbi.nlm.nih.gov/36928177/
10. Li, SiSi, Qi, YangFan, Yu, JiaChuan, Wang, Yang, Liu, Quentin. 2022. Nuclear Aurora kinase A switches m6A reader YTHDC1 to enhance an oncogenic RNA splicing of tumor suppressor RBM4. In Signal transduction and targeted therapy, 7, 97. doi:10.1038/s41392-022-00905-3. https://pubmed.ncbi.nlm.nih.gov/35361747/